Clinical Therapeutics

ASHP Foundation 1995 Pharmacy Practice Research Award
pp. 1003-1003(1)

Editorial comment
pp. 1004-1004(1)
Author: Krosnick A.

Angiotensin II receptor antagonism: Losartan-sites and mechanisms of action
pp. 1005-1030(26)
Author: Triggle D.J.

Editorial comment
pp. 1031-1031(1)
Author: Krosnick A.

Effectiveness and safety of beclomethasone dipropionate, an intranasal corticosteroid, in the treatment of patients with allergic rhinitis
pp. 1032-1041(10)
Author: Edwards T.B.

Editorial comment
pp. 1042-1042(1)
Author: Krosnick A.

Drug interactions in transplantation
pp. 1043-1061(19)
Author: Seifeldin R.

Risk of selected serious cardiac events among new users of antihistamines
pp. 1062-1077(16)
Authors: Staffa J.A.; Jones J.K.; Gable C.B.; Verspeelt J.P.; Amery W.K.

Comparison of the onset and intensity of action of intramuscular meloxicam and oral meloxicam in patients in acute sciatica
pp. 1078-1090(13)
Authors: Auvinet B.; Ziller R.; Appelboom T.; Velicitat P.

Ondansetron for nausea and vomiting associated with moderately emetogenic cancer chemotherapy
pp. 1091-1098(8)
Authors: DiBenedetto J.; Cubeddu L.X.; Ryan T.; Kish J.A.; Sciortino D.; Beall C.; Eisenberg P.D.; Henderson C.; Griffin D.; Wentz A.

Onset of action of aqueous beclomethasone dipropionate nasal spray in seasonal allergic rhinitis
pp. 1099-1109(11)
Authors: Selner J.C.; Weber R.W.; Wendell Richmond G.; Stricker W.E.; Norton J.D.

Gastrointestinal blood loss induced by bromfenac sodium, aspirin, and placebo
pp. 1110-1117(8)
Author: Cohen A.

Effect of prostaglandin E₁ on hepatic function after hepatectomy in patients with chronic liver disease
pp. 1118-1125(8)
Authors: Une Y.; Shimamura T.; Uchino J.

Effect of cilazapril therapy on glucose and lipid metabolism in patients with hypertension
pp. 1126-1135(10)
Authors: Shionoiri H.; Takasaki I.; Naruse M.; Nagamoti I.; Himeno H.; Ito T.; Ohtomi S.; Hata T.; Shindo K.; Mikami H.; Ogihara T.; Ishii M.; Cilazapril Multicenter Prospective Study Group in Japan

Effects of lisinopril and bisoprolol on lipoprotein metabolism in patients with mild-to-moderate essential hypertension
pp. 1136-1146(11)
Authors: Saku K.; Liu K.; Takeda Y.; Jimi S.; Arakawa K.

Acid suppression by famotidine 20 mg twice daily or 40 mg twice daily in preventing relapse of endoscopic recurrence of erosive esophagitis
pp. 1147-1156(10)
Authors: Simon T.J.; Roberts W.G.; Berlin R.G.; Hayden L.J.; Berman R.S.; Reagan J.E.

Pharmaceutical economics & health policy - Editorial comment
pp. 1158-1158(1)
Author: Sclar D.A.

Coprescribing of nonsteroidal anti-inflammatory drugs and cytoprotective and antiulcer drugs in Nova Scotia's senior population
pp. 1159-1173(15)
Authors: Kephart G.; Sketris I.; Smith M.; Maheu A.; Brown M.

Retrospective drug utilization review and the behavior of medicaid prescribers: an empirical marginal analysis
pp. 1174-1187(14)
Authors: Guo J.J.; Gibson J.T.; Hancock G.R.; Barker K.N.

Measuring the impact of patient counseling in the outpatient pharmacy setting: the research design of the Kaiser permanente/USC patient consultation study
pp. 1188-1206(19)
Authors: McCombs J.S.; Cody M.; Besinque K.; Borok G.; Ershoff D.; Groshen S.; Hay J.; Johnson K.A.; Nichol M.B.; Nye M.T.

Cost-effectiveness profiles with an expanding treatment population
pp. 1207-1212(6)
Author: Langley P.C.

Subject index to volume 17
pp. 1213-1217(5)

Author index to volume 17
pp. 1218-1223(6)